These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4375611)

  • 21. [Determination of estradiol receptors in target organs using radioautography].
    Arutiunian NA; Skopichev VG; Epshteĭn NZ; Tsyrlina VV
    Arkh Anat Gistol Embriol; 1987 May; 92(5):68-70. PubMed ID: 3619681
    [No Abstract]   [Full Text] [Related]  

  • 22. Early stages in estrogen control of gene expression and its derangement in cancer.
    Bresciani F; Nola E; Sica V; Puca GA
    Fed Proc; 1973 Nov; 32(11):2126-32. PubMed ID: 4359599
    [No Abstract]   [Full Text] [Related]  

  • 23. Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness.
    Bakas P; Liapis A; Vlahopoulos S; Giner M; Logotheti S; Creatsas G; Meligova AK; Alexis MN; Zoumpourlis V
    Fertil Steril; 2008 Nov; 90(5):1878-85. PubMed ID: 18166184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibition of the uterine binding of estrogens by unsaturated fatty acids in immature female rats].
    Clerc-Hofmann F; Vallette G; Secco-Millet C; Christeff N; Benassayag C; Nunez EA
    C R Seances Acad Sci III; 1983 Jan; 296(1):53-8. PubMed ID: 6404509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor characteristics of specific estrogen binding in the renal adenocarcinoma of the golden hamster.
    Li JJ; Talley DJ; Li SA; Villee CA
    Cancer Res; 1976 Mar; 36(3):1127-32. PubMed ID: 175953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of sulfate conjugation in estrogen metabolism and activity.
    Brooks SC; Rozhin J; Pack BA; Horn L; Godefroi VC; Locke ER; Zemlicka J; Singh DV
    J Toxicol Environ Health; 1978; 4(2-3):283-300. PubMed ID: 351200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.
    Wu M; Gunning W; Ratnam M
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clear cell adenocarcinoma of the uterus--ultrastructural and hormonal study.
    Horie A; Yasumoto K; Ueda H; Watanabe Y; Kotoo Y; Kurita Y
    Acta Pathol Jpn; 1977 Nov; 27(6):907-15. PubMed ID: 605800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-esterified fatty acids and alpha 1-fetoprotein are the modulators of uterine binding of estrogens during development in the rat].
    Vallette G; Benassayag C; Christeff N; Clerc F; Nunez EA
    Dev Pharmacol Ther; 1984; 7 Suppl 1():30-7. PubMed ID: 6083854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uterine preparation for implantation in the mouse is associated with coordinate expression of estrogen-responsive finger protein and estrogen receptor.
    Das N; Wang J; Dey SK
    Mol Reprod Dev; 1997 Apr; 46(4):499-506. PubMed ID: 9094097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The biological role of estriol].
    Persianinov LS; Sturchak SV; Bobrova EG; Shchedrina RN; Fanchenko ND
    Biull Eksp Biol Med; 1975 May; 79(5):93-6. PubMed ID: 179639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.
    Gulino A; Pasqualini JR
    Cancer Res; 1982 May; 42(5):1913-21. PubMed ID: 7066903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen-receptor binding: relationship to estrogen-induced responses.
    Clark JH; Peck EJ; Anderson JN
    J Toxicol Environ Health; 1976 Mar; 1(4):561-86. PubMed ID: 177788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steroid-independent regulation of uterine oxytocin receptors.
    Siebel AL; Gehring HM; Parry LJ
    J Neuroendocrinol; 2004 Apr; 16(4):398-402. PubMed ID: 15089981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal characteristics of patients with endometrial hyperplasia and carcinoma [proceedings].
    Siiteri PK
    Acta Cytol; 1980; 24(6):482-3. PubMed ID: 6934673
    [No Abstract]   [Full Text] [Related]  

  • 36. [Co-occurrence of hyperplasia, endometrial carcinoma and uterine myoma: role of sex hormones, their receptors and enzymes of estrogen metabolism].
    Bochkareva NV; Kolomiets LA; Kondakova IV
    Vopr Onkol; 2005; 51(4):427-33. PubMed ID: 16308973
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes of sex steroid hormone receptors in rat uterine cytosol during experimental induction of endometrial carcinoma (author's transl)].
    Nagasaka T
    Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):757-66. PubMed ID: 6454322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor. Therapeutic guide in undifferentiated metastatic carcinoma in women.
    Golomb HM; Thomsen S
    Arch Intern Med; 1975 Jul; 135(7):942-5. PubMed ID: 168822
    [No Abstract]   [Full Text] [Related]  

  • 39. [Continuous or persistent estrogen secretion in the etiology of uterine cancer].
    ROUX G; MARCHAL G; LOUBATIERES R
    Brux Med; 1955 Apr; 35(17):827-41. PubMed ID: 14378706
    [No Abstract]   [Full Text] [Related]  

  • 40. The mucins of the normal and cancerous uterine mucosa.
    MOORE RB; REAGAN JW; SCHOENBERG MD
    Cancer; 1959; 12(2):215-21. PubMed ID: 13638939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.